Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADN.L Directors Deals (ADN)

  • There is currently no data for ADN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Deals for ADN.L (ADN)

Announced Traded Action Notifier Price Currency Amount Holding
25-Jul-0522-Jul-05BuyDonald Waters held the position of Non-Executive Director at the time of this trade.Donald Waters154.80GBX9,000-
02-Feb-0531-Jan-05BuyJohn Wybrew held the position of Director at the time of this trade.John Wybrew112.50GBX50,00050,000
19-Jan-0519-Jan-05BuyRoger Cornick held the position of Non-Executive Chairman at the time of this trade.Roger Cornick106.00GBX4,400-
10-Jan-0510-Jan-05BuyAnita Frew held the position of Non-Executive Director at the time of this trade.Anita Frew109.67GBX15,00037,500
31-Mar-0430-Mar-04Exercise of OptionW J Rattray held the position of CFO at the time of this trade.W J Rattray91.00GBX110,0001,924,179
31-Mar-0430-Mar-04Exercise of OptionMartin J Gilbert held the position of CEO at the time of this trade.Martin J Gilbert91.00GBX150,000215,512
16-Sep-0315-Sep-03BuyMartin J Gilbert held the position of CEO at the time of this trade.Martin J Gilbert70.00GBX100,000215,512
17-Jan-0317-Jan-03BuyW J Rattray held the position of CFO at the time of this trade.W J Rattray--50,0001,924,179
17-Jan-0317-Jan-03BuyMartin J Gilbert held the position of CEO at the time of this trade.Martin J Gilbert--50,000215,512
03-May-0103-May-01BuyChristopher (Chris) Giles Herr Weaver held the position of Director at the time of this trade.Christopher (Chris) Giles Herr Weaver500.00GBX10,000-

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.